Champions Oncology Inc Stock
Your prediction
Champions Oncology Inc Stock
Champions Oncology Inc shows a slight decrease today, losing -€0.020 (-0.430%) compared to yesterday.
Pros and Cons of Champions Oncology Inc in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
S********** s********
Cons
?
C******** o* t** e**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Champions Oncology Inc vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Champions Oncology Inc | -0.430% | 0.427% | -4.472% | 2.174% | -2.490% | -47.191% | - |
Ardelyx Inc. | 0.910% | -5.482% | -15.972% | 32.578% | 3.218% | -12.905% | - |
Salarius Pharmaceuticals Inc. | 4.250% | -0.935% | -18.462% | -68.120% | -23.604% | -98.261% | -99.994% |
Brainstorm Cell | 1.170% | -0.896% | -1.485% | -81.710% | 114.440% | -80.717% | - |
News
3 Dividend Champions with room for dividend growth
The World Series champion Texas Rangers recently paid nice dividends for sports bettors. For stock investors, there's a different, more predictable group of dividend payers worth betting on — the
Champions Oncology's European Research Operations Site Receives ISO-9001:2015 Accreditation and ATS Certification
HACKENSACK, NJ / ACCESSWIRE / November 2, 2023 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology